Sign in

CIK 0000908259

  • Non-accelerated filer
  • Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133679168
Phone
+1 650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 50,000 shares at an average $4.63 ($231,673)
  3. 4 Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 80,000 shares (grant or award)
  5. 4 Grant or award Director acquired 80,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  7. 4 Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
  8. 4 Grant or award Director acquired 40,000 shares (grant or award)
  9. 4 Grant or award Director acquired 40,000 shares (grant or award)
  10. 4 Grant or award Director acquired 40,000 shares (grant or award)
  11. 4 Grant or award Director acquired 40,000 shares (grant or award)
  12. 4 Returned to the company Director returned 10,856 shares (to the company)
  13. 4 Open-market buy Director bought 4,000 shares at $4.75 ($19,000)
  14. 4 Open-market buy Director bought 1,000 shares at $4.51 ($4,510)
  15. 4 Open-market buy Director bought 101,600 shares at $4.52 ($459,232)
  16. 4 Open-market buy Director bought 15,000 shares at $4.48 ($67,200)
  17. 4 Open-market buy Director bought 25,000 shares at $4.37 ($109,250)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 13 of 17 · 325 filings